{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:11:54Z","timestamp":1780380714038,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jval.2025.01.001","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:55:49Z","timestamp":1737978949000},"page":"959-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations"],"prefix":"10.1016","volume":"28","author":[{"given":"Zixuan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Keat","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2025.01.001_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jval.2025.01.001_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.jval.2025.01.001_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jval.2025.01.001_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242415","article-title":"Diagnostic accuracy of tests for type 2 diabetes and prediabetes: a systematic review and meta-analysis","volume":"15","author":"Kaur","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jval.2025.01.001_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.diabres.2007.10.022","article-title":"A simple clinical score for type 2 diabetes mellitus screening in the Canary Islands","volume":"80","author":"Cabrera De Le\u00f3n","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jval.2025.01.001_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pcd.2018.07.015","article-title":"Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population","volume":"12","author":"Bernabe-Ortiz","year":"2018","journal-title":"Prim Care Diabetes"},{"issue":"8","key":"10.1016\/j.jval.2025.01.001_bib8","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2337\/dc10-0843","article-title":"Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review","volume":"33","author":"Li","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jval.2025.01.001_bib9","first-page":"326","article-title":"Cost effectiveness of type 2 diabetes screening: a systematic review","volume":"30","author":"Najafi","year":"2016","journal-title":"Med J Islam Repub Iran"},{"issue":"2","key":"10.1016\/j.jval.2025.01.001_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/03007995.2016.1257977","article-title":"Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetes","volume":"33","author":"Einarson","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"17","key":"10.1016\/j.jval.2025.01.001_bib11","doi-asserted-by":"crossref","DOI":"10.3310\/hta11170","article-title":"Screening for type 2 diabetes: literature review and economic modelling","volume":"11","author":"Waugh","year":"2007","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3803\/EnM.2022.105","article-title":"Recent updates to clinical practice guidelines for diabetes mellitus","volume":"37","author":"Yu","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.jval.2025.01.001_bib63","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2025.01.001_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.880799","article-title":"Economic evaluation of using polygenic risk score to guide risk screening and interventions for the prevention of type 2 diabetes in individuals with high overall baseline risk","volume":"13","author":"Martikainen","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jval.2025.01.001_bib15","article-title":"Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions","volume":"356","author":"Barry","year":"2017","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.jval.2025.01.001_bib16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.4239\/wjd.v6.i17.1337","article-title":"Evaluation of the Finnish Diabetes Risk Score to predict type 2 diabetes mellitus in a Colombian population: a longitudinal observational study","volume":"6","author":"Gomez-Arbelaez","year":"2015","journal-title":"World J Diabetes"},{"issue":"8","key":"10.1016\/j.jval.2025.01.001_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/00325481.2020.1821234","article-title":"Evaluation of the value of diabetes risk scores in screening for undiagnosed diabetes and prediabetes: a community-based study in southwestern China","volume":"132","author":"Xu","year":"2020","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.jval.2025.01.001_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pcd.2013.08.003","article-title":"Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study","volume":"7","author":"Zhang","year":"2013","journal-title":"Prim Care Diabetes"},{"issue":"2","key":"10.1016\/j.jval.2025.01.001_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/dc09-0947","article-title":"Familial risks for type 2 diabetes in Sweden","volume":"33","author":"Hemminki","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jval.2025.01.001_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jval.2021.09.013","article-title":"Genetic-guided pharmacotherapy for atrial fibrillation: a systematic and critical review of economic evaluations","volume":"25","author":"Kamil","year":"2022","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"09","key":"10.1016\/j.jval.2025.01.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-6156.1000438","article-title":"Cost-effectiveness of therapeutic education to prevent the development and progression of type 2 diabetes: systematic review","volume":"5","author":"Odnoletkova","year":"2014","journal-title":"J Diabetes Metab"},{"issue":"2","key":"10.1016\/j.jval.2025.01.001_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria","volume":"21","author":"Evers","year":"2005","journal-title":"Int J Technol Assess Healthcare"},{"issue":"4","key":"10.1016\/j.jval.2025.01.001_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00592-019-01451-1","article-title":"Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: a cost-effectiveness analysis","volume":"57","author":"M\u00fchlenbruch","year":"2020","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12902-021-00771-0","article-title":"Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification","volume":"21","author":"Ohde","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10729-021-09575-z","article-title":"Optimizing diabetes screening frequencies for at-risk groups","volume":"25","author":"Wu","year":"2022","journal-title":"Healthcare Manag Sci"},{"issue":"11","key":"10.1016\/j.jval.2025.01.001_bib28","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/dme.14330","article-title":"Alternative type 2 diabetes screening tests may reduce the number of U.S. adults with undiagnosed diabetes","volume":"37","author":"Dadwani","year":"2020","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00592-022-01963-3","article-title":"A simulation model estimates lifetime health and economic outcomes of screening prediabetes using the 1-h plasma glucose","volume":"60","author":"Andellini","year":"2022","journal-title":"Acta Diabetol"},{"issue":"9","key":"10.1016\/j.jval.2025.01.001_bib30","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1111\/poms.13422","article-title":"An analytics-driven approach for optimal individualized diabetes screening","volume":"30","author":"Kamalzadeh","year":"2021","journal-title":"Prod Oper Manag"},{"issue":"2","key":"10.1016\/j.jval.2025.01.001_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/1735-5362.367799","article-title":"Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran","volume":"18","author":"Amirsadri","year":"2023","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.jval.2025.01.001_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1018084","article-title":"Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China","volume":"10","author":"Hao","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib33","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/S2468-2667(21)00199-7","article-title":"Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study","volume":"7","author":"Kaur","year":"2022","journal-title":"Lancet Public Health"},{"issue":"12","key":"10.1016\/j.jval.2025.01.001_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261231","article-title":"Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam","volume":"16","author":"Toi","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1186\/s12913-021-06948-6","article-title":"Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis","volume":"21","author":"Jalkanen","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.jval.2025.01.001_bib36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amepre.2012.01.003","article-title":"Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention","volume":"42","author":"Zhuo","year":"2012","journal-title":"Am J Prev Med"},{"issue":"12","key":"10.1016\/j.jval.2025.01.001_bib37","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.2337\/dc13-0497","article-title":"Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged \u226545 years","volume":"36","author":"Zhuo","year":"2013","journal-title":"Diabetes Care"},{"issue":"9723","key":"10.1016\/j.jval.2025.01.001_bib38","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(09)62162-0","article-title":"Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis","volume":"375","author":"Kahn","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jval.2025.01.001_bib39","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2337\/dc10-0054","article-title":"Screening adults for pre-diabetes and diabetes may be cost-saving","volume":"33","author":"Chatterjee","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jval.2025.01.001_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11532880-000000000-00000","article-title":"Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany","volume":"8","author":"Schaufler","year":"2010","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.jval.2025.01.001_bib41","first-page":"91","article-title":"Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation","volume":"4","author":"Mortaz","year":"2012","journal-title":"Clinicoecon Outcomes Res"},{"issue":"7","key":"10.1016\/j.jval.2025.01.001_bib42","first-page":"833","article-title":"Cost and effectiveness of screening methods for abnormal fasting plasma glucose among Thai adults participating in the annual health check-up at King Chulalongkorn Memorial Hospital","volume":"94","author":"Srichang","year":"2011","journal-title":"J Med Assoc Thai"},{"issue":"12","key":"10.1016\/j.jval.2025.01.001_bib43","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1377\/hlthaff.2010.0819","article-title":"Potential savings in Mexico from screening and prevention for early diabetes and hypertension","volume":"29","author":"Castro-R\u00edos","year":"2010","journal-title":"Health Aff"},{"issue":"4","key":"10.1016\/j.jval.2025.01.001_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pcd.2010.06.003","article-title":"Comparison of different stepwise screening strategies for type 2 diabetes: finding from Danish general practice, Addition-DK","volume":"4","author":"Dalsgaard","year":"2010","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"10.1016\/j.jval.2025.01.001_bib45","first-page":"294","article-title":"Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians","volume":"133","author":"Mohan","year":"2011","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13098-015-0090-8","article-title":"Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience","volume":"7","author":"Toscano","year":"2015","journal-title":"Diabetol Metab Syndr"},{"issue":"33","key":"10.1016\/j.jval.2025.01.001_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19330","article-title":"The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study","volume":"19","author":"Gillett","year":"2015","journal-title":"Health Technol Assess"},{"issue":"7","key":"10.1016\/j.jval.2025.01.001_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/dmrr.2791","article-title":"Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes: cost-effectiveness of T2DM Screening","volume":"32","author":"Nagy","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.jval.2025.01.001_bib49","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/dc17-1307","article-title":"Cost-effectiveness of a new opportunistic screening strategy for walk-in fingertip HbA1c testing at community pharmacies in Japan","volume":"41","author":"Shono","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jval.2025.01.001_bib50","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/dme.13349","article-title":"Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK","volume":"34","author":"Breeze","year":"2017","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12944-016-0234-3","article-title":"Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts","volume":"15","author":"Mamtani","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jval.2025.01.001_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.diabres.2017.05.009","article-title":"Clinical applicability and cost-effectiveness of diabscore in screening for type 2 diabetes in primary care","volume":"130","author":"Rodr\u00edguez-P\u00e9rez","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jval.2025.01.001_bib53","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00125-018-4594-2","article-title":"Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009","volume":"61","author":"Sorts\u00f8","year":"2018","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/j.jval.2025.01.001_bib54","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcjd.2017.10.004","article-title":"Screening for diabetes in adults","volume":"42","author":"Ekoe","year":"2018","journal-title":"Can J Diabetes"},{"issue":"8","key":"10.1016\/j.jval.2025.01.001_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182192","article-title":"Discordance in the diagnosis of diabetes: comparison between HbA1c and fasting plasma glucose","volume":"12","author":"Ho-Pham","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29998-z","article-title":"Screening for diabetes with HbA1c: test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore","volume":"8","author":"Lim","year":"2018","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.jval.2025.01.001_bib58","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.3390\/ijerph17165723","article-title":"A systematic review of the economic burden of type 2 diabetes in Malaysia","volume":"17","author":"Ganasegeran","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.jval.2025.01.001_bib59","doi-asserted-by":"crossref","DOI":"10.1080\/20523211.2024.2322107","article-title":"A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries","volume":"17","author":"Butt","year":"2024","journal-title":"J Pharm Policy Pract"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T22:47:04Z","timestamp":1753310824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1098301525000191"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.01.001","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}